Summary A proteolysis-inducing factor (PIF) isolated from a cachexia-inducing murne tumour (MAC16) produced a decrease in body weight (1.6 g, P. 0.01 compared with control subjects) within 24 h after i.v. administration to non-tumour-bearing mice. Weight loss was associated with significant decreases in the weight of the spleen and soleus and gastrocnemius muscles. with no effect on the weight of the heart or kidney and with an increase in weight of the liver. Protein degradation in isolated soleus muscle was signfficantly increased in mice bearing the MAC16 tumour. To define which proteolytic pathways contribute to this increase, soleus muscles from mice bearing the MAC16 tumour and non-tumour-bearing animals administered PIF were incubated under conditions that modify different proteolytic systems. In mice bearing the MAC16 tumour, there were increases in both cathepsin B and L, and the Ca2--dependent lysosomal and ATP-dependent pathways were found to contribute to the increased proteolysis; whereas, in PIF-injected animals, there was activation only of the ATP-dependent pathway. Further studies in mice bearing the MAC16 tumour have provided evidence for increased levels of ubiquitin-conjugated proteins and increased mRNA levels for the 14 kDa ubiquitin carrier protein E2 and the C9 proteasome subunit in gastrocnemius muscle, suggesting activation of the ATP-ubiquitin-dependent proteolytic pathway. A monoclonal antibody to PIF attenuated the enhanced protein degradation in soleus muscle from mice bearing the MAC16 tumour, confirming that PIF is responsible for the loss of skeletal muscle in cachectic mice.
W'eight loss is an important prognostic factor in determinin2 the ox erall sur ix al of the cancer patient (Shamberger. 1984) . Although cancer cachexia is associated w-ith depletion of both adipose tissue and skeletal muscle mass. it is x-isceral protein and lean body mass depletion (as assessed by serum albumin concentration and creatinine-heijht index) rather than adipose depletion that haxe a w-orse prognostic impact (Nixon et al. 1980) . Peripheral muscle w asting may be due to increased muscle catabolism or decreased protein synthesis. or a combination of the tx-o.
An increased rate of w hole-body protein turnox er has been reported in patients Awith colorectal cancer (Carmichael et al. 1980) and non-oat-cell lung cancer (Melville et al. 1990) . although the incorporation of leucine into skeletal muscle of cancer patients has also been found to be decreased (Lundholm et al. 1978) .
To study this phenomenon. we have utilized the MAC 16 murine model of cachexia. which produces a decrease in muscle mass in direct proportion to the w-eight of the tumour (Beck and Tisdale. 1987 ). This effect has been attributed to the production by the tumour of a circulating proteoly sis-inducing factor (PIF). which is capable of initiating muscle catabolism in xitro (Smith and Tisdale. 1993) . This material has now been purified to homoceneitv and showxn to be a sulphated glycoprotein of apparent molecular w eight of 24 kDa Todorox et al. 1996a) . the actixitx-of w hich can be neutralized by a monoclonal antibodx derix ed from splenocxtes of mice bearin2 the MAC16 tumour (Todorox at al.
1996b.)
Received 4 August 1997 Revised 25 March 1998 Accepted 31 March 1998 Correspondence to: MJ Tisdale Several proteolxtic pathwaxys are involxed in the intracellular degradation of proteins in skeletal muscle: the l-sosomal proteases. including the c! steine proteases. cathepsins B. H and L. and the aspartate protease cathepsin D (Bird et al. 1980 ): a non-I sosomal pathway involx ing the Ca'-actix ated cysteine proteases calpain I and II (Waxman. 1981) : an ATP-ubiquitin-dependent proteolxtic pathwax (Hershko and Ciechanoxer. 1992) : and a nonlx sosomal ATP-dependent protease that cleaxes proteins that are not conjugated to ubiquitin (Fagan and Waxman. 1989) . The ATP-ubiquitin-dependent proteolytic pathwax plaxys an important role in muscle protein degradation induced by starvation (Wine and Goldberg. 1993) . sepsis (Tiao et al. 1994) . metabolic acidosis (Mitch et al. 1994) . denerxation atrophv (Medina et al. 1995) and cachexia induced by the Yoshida ascites hepatoma in rats (Llo era et al. 1994 : Baracos et al. 1995 .
The present studx was initiated to determine which proteolytic pathxwax is actix ated in skeletal muscle after administration of PIF to non-tumour-bearing mice. and to compare the effect w-ith that found in skeletal muscle of mice bearing the MAC 16 tumour.
MATERIALS AND METHODS Animals
Pure strain female NNIRI mice w-ere obtained from our ow-n breeding colonv and were fed a rat and mouse breeding diet )Pilsbur-. Birmin-ham. UK) and wxater ad libitum. Animals (axerage bodv w-eight 20 g) were transplanted with fragments of the MAC16 tumour into the flank by means of a trocar as prexiouslv described (Beck and Tisdale. 1987 chromatography using a monoclonal antibody purified as described previously (Todorov et al. 1996b ). The immunogenic fractions were further purified by hydrophobic chromatography using a Brownlee Aquopore RP-300 C8 column and a gradient of acetonitrile in water (Todorov et al. 1996a (Todorov et al. . 1996b ).
Effect of proteolysis-inducing factor on body weight Detemination of the mechanism of muscle protein degradation Animals were killed by cervical dislocation and the soleus muscles were quickly dissected out together with the intact tendons and mounted on stainless-steel supports at resting length. They were then transferred to 3 ml of oxygenated (95% oxygen:5% carbon dioxide) Krebs-Henseleit bicarbonate buffer, pH 7.4. containing 5 mm glucose together with 0.5 n-m. cycloheximide, to prevent reincorporation of amino acids released during proteolysis.
Muscles were preincubated for 45 min (except for energydepleting experiments, when the preincubation was for 60 min) at 37°C followed by an additional 2 h, during which the release of tyrosine was determined by the fluorimetric method of Waalkes and Udenfriend (1957) . Tyrosine release gives a measurement of total protein degradation. because tyrosine rapidly equilibrates between intracellular pools and the medium and is neither synthesized nor degraded.
To test the role of lysosomal proteolysis. muscles were incubated in medium as described above or in medium containing 10 mms ammonium chloride. 250 jim chloroquine and 10 mtm methylamine to block lysosomal acidification, together with 30 jim leupeptin. which inhibits lysosomal proteases (Lowell et al. 1986 : Tawa et al. 1992 : Baracos et al. 1995 .
The role of calcium-dependent proteolysis was determined by incubating muscles in medium from which calcium had been omitted or in normal Krebs-Henseleit buffer that contained 2.5 m-s calcium. In addition. muscles were incubated in the absence or presence of trans-epoxysuccinyl-L-leucylamido(4-guanidino)butane (E-64. 100 jM). which blocks calpains I and I (Barrett et al. 1982) .
Muscles were also incubated in the presence of 10 mm methylamine to inhibit lysosomal protein degradation so that differences in tyrosine release by muscles incubated with or without E-64 reflected calcium-dependent proteolysis. For the determination of both lysosomal and calcium-dependent proteolysis. the different substances were present during both the preincubation period and the 2 h incubation (Tawa et al. 1992 : Baracos et al. 1995 .
To study the role of energy-dependent proteolysis, muscles were depleted of intracellular ATP by a 1 h preincubation in medium containing 5 m-m deoxyglucose (2-DG) and 0.2 mim sodium azide in the absence of glucose. The muscles were then incubated for a further 2 h and the tyrosine released compared with that from muscles incubated in the presence of 5 mm glucose. Both sets of muscles were incubated in Ca'+-free medium containing 10 mm methylamine, 1 mU ml-' insulin and leucine. isoleucine and valine present at concentrations five times that found in the plasma of NMRI mice (Beck and Tisdale. 1989 ) to block lysosomal protein degradation. Thus. changes in tyrosine release reflect non-lysosomal, Ca+-independent, energy-dependent proteolysis (Tawa et al. 1992; Baracos et al. 1995) .
Assay of cathepsins L and B
Animals were killed by cervical dislocation and the gastrocnemius and soleus muscles were removed, trimmed completely of any connective tissue and infringing muscle and washed twice with 10 ml of 250 mm sucrose. 2 nims EGTA. 2 m-m EDTA and 20 mm Tris HCI. pH 7.4. The muscles were then individually homogenized in 1 ml of 250 mm sucrose. 2 mM EGTA. 2 mms EDTA. 20 msm Tris HCI. pH 7.4. containing 0.2% Triton X-100. followed by sonication. The supematants formed after centrifugation at 18 000 g for 15 min were used to determine cathepsin activity.
For cathepsin L, the incubation mixture contained 0.1% Brij 35 in water (495 jl). (5 ji) supematant. 340 rms sodium acetate. 60 mm acetic acid. pH 5.5. 4 mM EDTA and 8 mM dithiothreitol (250 gl). and was preincubated for 5 min at 30°C before adding the substrate N-CBZ-PHE-ARG-7-amido-4-methylcoumarin (5 nmoles in 250 jl). After 10 min at 30°C. the reaction was terminated by addition of 1 ml of 100 mM trichloroacetic acid. 100 mtm sodium hydroxide. 30 mm sodium acetate and 70 mM acetic acid, pH 4.3. The fluorescence of the free aminomethylcoumarin was determined at an excitation wavelength of 370 nm and an emission wavelength of 430 nm.
Cathepsin B was assayed in a similar manner using a buffer composed of 352 mM potassium dihydrogen phosphate and 48 mm disodium hydrogen phosphate. pH 6.0. 4 mm EDTA. 8 mm cysteine and Na-CBZ-Arg-Arg-7-amido-4-methylcoumarin (2.5 nmol in 250 gil) as substrate. The reaction was conducted for lOmin at 400C and ternminated with 1 ml of l00 m sodium chloroacetate. 30 mrs sodium acetate and 70 mm acetic acid. pH 4.3. One unit of enzyme activity is defined as that amount which catalyses the formation of 1 pmol of product from substrate during the 10 min incubation period.
RNA isolation and Nortrn blot analysis
Total RNA was extracted from gastrocnemius and soleus muscles. and heart and liver using the acid guanidinium isothiocyanate/ phenollchloroform-isoamylalcohol method (Chomezynski and Sacchi. 1987 ) and quantitated by absorbance at 260 nm.
The RNA was denatured by heating at 65°C for 10 min and samples (10 jg) were subjected to electrophoresis on 1.2% agarose gels containing 0.67% formaldehyde and transferred onto a Genescreen membrane (NEN Research Products. MA. USA) overnight by capillary action. The RNA was cross-linked to the 
RESULTS
The changes in total bodv wxeight and the wxeight of some indixidual organs 24 h after administration of the PIF to female NMRI mice are showxn in Table 1 . Whereas control animals shoxxed a small wei2ht increase 10.7%-). there wxas a siunificant (P < 0.01) decrease in oxerall bodx weight (8.6%) in treated animals. The effect on the tissues and oruans was x-ariable. Thus. there wxas a sinificant decrease in the weight of the soleus and g!astrocnemius muscles and spleen. no change in the xxeight of the heart and kidnev. but an increase in weight of the lixer (Table 1. To determine the mechanism for the selectixve depletion of skeletal muscle in cachexia a comparison has been made on the loss of soleus muscle induced bv PIF and the MAC16 tumour.
The effect of blocking l-sosomal function wxith methxlamine. an inhibitor of l-sosomal acidification. on protein degradation induced bv the MAC 16 tumour was inxestigated (Table 2 ). There wxas an increased catabolism of soleus muscle proteins in mice A bearinc the MAC 16 tumour. and methylamine caused a significant decrease in overall proteolysis in soleus muscle of tumour-bearing mice but not in non-tumour-bearing controls. Thus. there is a rise in the lysosomal proteolytic process in muscles of mice bearing the MAC16 tumour. This was confirmed by measurement of the level of the lysosomal enzymes cathepsins L and B. There was an elevation of cathepsin L in the soleus muscle from mice bearing the MAC16 tumour (Table 3) and an increase in cathepsin B in gastrocnemius muscle. This suggests that a significant proportion of the increased proteolysis was due to an elevation of these lysosomal enzymes.
To determine whether the increase in protein degradation was also due to activation of the non-lysosomal calcium-dependent pathway. soleus muscles from tumour-bearing, and non-tumourbearing mice were incubated under conditions known to block calpains I and II and in the absence of calcium. There was a significant reduction in the rate of protein degradation in the soleus muscle of mice bearing the MAC 16 tumour but not in the nontumour-bearing control group ( Table 4 ). suggesting that the calcium-dependent pathway also contributed to protein degradation in skeletal muscle of mice bearing the MAC 16 tumour.
To study the role of the ATP-dependent pathway in protein degradation in soleus muscle induced by the MAC 16 tumour. muscles were depleted of ATP after blocking lysosomal and calcium-dependent proteolytic pathways. Under these conditions. protein degradation in non-tumour-bearing animals was not significantly reduced. whereas protein degradation in tumour-bearing mice was significantly reduced (Table 5 ). There was no significant difference in protein degradation between tumour-bearing and control muscles in the presence of inhibitors. Under these conditions. the ATP content of the muscles was reduced by an average of 73%. Thus, an ATP-dependent non-lysosomal pathway appears to play a major role in the excessive proteolysis of skeletal muscle in mice bearing the MAC 16 tumour.
To investigate whether this was dependent on ubiquitin. gastrocnemius muscle from mice bearing the MAC 16 tumour was homogenized and the soluble protein was subjected to electrophoresis. immunoblotted and probed with an antibody that specifically recognized ubiquitin-conjugated proteins. As reported by (Figure 1 ). This suggests that the ATP-ubiquitin-dependent proteolI tic pathw-ay w as activated. Because ubiquitin has roles other than in proteolI-sis ( St John et al. 1986 ). the mRNA encoding other components of the pathway was inx estigrated. Equal amounts of RNA from gastrocnemius muscles of non-tumour-bearinm mice. mice bearing0 the non-cachexiainducing MAC 13 tumour and the MAC 16 tumour were compared bx Northern hNbridization analvsis. The RNA blots w-ere probed with the cDNA of the 14-kDa ubiquitin carrier protein E2. which either ligates the ubiquitin directlx to the target protein or does so in the presence of ubiquitin protein ligase. Two mRNA transcripts of 1.2 and 1.8 kb w-ere detectable w-ith this probe. arising from different sites of polvadenylation (Figure 2 ). Although there was on1v a small change in the level of expression of the 1.8 kb transcript (26%k increase). there >-as a large atwofold) increase in the expression of the 1.2 kb transcript in gastrocnemius muscle of mice bearing the MAC16 tumour and onlv a small increase in muscle from mice bearing the MAC13 tumour. The RNA blots w-ere also probed for the C9 subunit of the 20S proteasome. the proteolvtic core of the 26S proteasome which degrades ubiquitin conjugates (Hershko and Ciechanover. 1992) (Figure 3 ). This show-ed a threefold increase in the 1.3 kb transcript in the gastrocnemius muscle of mice bearing the MIAC 16 tumour. w-ith no significant change in muscle from mice bearing the MAC 13 tumour. Control experiments showed that the level of mRNA for GAPDH. a housekeeping gene unrelated to protein breakdow-n. Awas similar in all three groups of mice (results not shown). confirminc that the differences in mRNA for steps in the -ATP-ubiquitin-dependent proteolytic pathw-ay in skeletal muscle of mice bearinr the MAC16 tumour were not due to non-specific changes in the levels of all mRNA transcripts. The effect of PIF on protein degradation in soleus muscle is show-n in Table 6 . In this case. onlv the ATP-dependent non-ly sosomal pathw ay was actix ated. with no contribution from either the (Fagan et al. 1987 ) and the other independent (Fagan and Waxman. 1989 ). The former system has been suggested to be mainly responsible for muscle atrophy in Yoshida sarcoma-bearing rats (Temparis et al. 1994 ) and those bearing the Yoshida ascites hepatoma (Baracos et al. 1995 (Beck and Tisdale. 1987 ). An enhanced production of proteasomes also seems likelv from the threefold rise in the mRNA for the proteasome subunit C9. The ATP-dependent. but not the lysosomal. pathway was also activated in soleus muscle of non-tumour-bearin, mice 24 h after administration of PIF. although experinents have not been performed to date to investigate whether this is the ubiquitindependent pathway. However. it is likely that PIF contributes directly to the activation of this pathwav in skeletal muscle of mice bearinc the MAC16 tumour, because antibodies to PIF attenuate the degradation of skeletal muscle proteins. There are other potential mediators such as tumour necrosis factor (x (TNT-a) and interleukin 6 (IL-6). which could act in vivo. TNF-a has been shown to produce an increase in ubiquitin aene expression in -itro after incubation for 180 mmn. although there was no change in the expression of the C8 proteasome subunit. which may require a longer time interval for induction (Llovera et al. 1997 ). IL-6 has also been found to increase the activity of the 26S proteasome in murine C2C, myotubes in vitro (Ebisui et al. 1995) . However. our previous studies (Mulligan et al. 1992 ) have failed to find anv evidence for an involvement of either TNT-a or IL-6 in the process of cachexia induced by the MAC 16 tumour. suggestinc that PIF may be directly involved. Further studies are required to dissect out the molecular pathways involved in protein degradation.
